Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy

• Status: Terminated
• Trial end date: 2009-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The majority of kidney stones are treated with shock wave lithotripsy (SWL). We are examining if the medication Flomax will result in improved stone passage rates following SWL.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Emory University
• Treatments: Polystyrene sulfonic acid; Tamsulosin

Criteria

Inclusion Criteria:

• Patients 18 years old and above with urolithiasis scheduled for shock wave lithotripsy.

Exclusion Criteria:

• Contraindications to Flomax

• Patients with renal impairment (serum creatinine above 2.0)

• Patients with hepatic impairment (liver enzymes 2.5 times the upper limit of normal)

• Use of other oral alpha blockers